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BACKGROUND There is limited data on plaque tissue characterization
and phenotype classiﬁcation using radiofrequency iMAP-IVUS
(intravascular ultrasound, Boston Scientiﬁc, USA).
METHODS In the iWonder study pts presenting with non-ST-eleva-
tion myocardial infarction (STEMI) or STEMI underwent 3-vessel
grayscale IVUS and iMAP tissue characterization prior to percu-
taneous intervention. In total, 385 lesions from 100 pts were
divided into culprit (n¼100) and non-culprit (n¼285) lesions deﬁned
as >40% of plaque burden longer than 1.5mm in length. Using
iMAP vessel and lumen were analyzed for all available frames
(approximately every 0.5mm); and volumes were calculated using
Simpson’s rule. Lesion phenotype was classiﬁed in a hierarchical
fashion into: (1) TCFA (thin-cap ﬁbroatheroma – at least 1 frame
with >30 of necrotic core [NC] abutting to the lumen); (2) ThCFA
(NC >10%, conﬂuent dense calcium [DC] >10%, well-deﬁned ﬁbrous
cap); (3) PIT (pathological intimal thickening – mainly ﬁbrofatty
tissue, <10% conﬂuent NC); (4) ﬁbrotic plaque (mainly ﬁbrous
tissue, <10% conﬂuent NC, <10% conﬂuent DC) and (5) ﬁbrocalciﬁc
plaque (mainly ﬁbrous tissue, >10% conﬂuent DC and <10%
conﬂuent NC).
RESULTS Culprit lesions had smaller minimum lumen area with
greater plaque burden compared to non-culprit lesions. Volumetric
analysis showed that culprit lesions had longer length and larger
vessel and plaque volumes compared to non-culprit lesions (Table).
iMAP-IVUS revealed that culprit lesions presented more NC and
ﬁbrofatty volume, both at lesion level and at the minimum lumen
area (MLA) site (all p<0.001). Also, a TCFA was more prevalent
within culprit vs. non-culprit lesions (39.0% vs. 19.0%, p<0.001)
anywhere within the lesion as well as at the MLA site (18.0% vs.
9.5%, p¼0.07).Culprit lesion (n[100)Non-culprit lesion
(n[285) P-valueMinimum lumen area
(mm2)2.1 [1.4, 7.5] 3.9 [1.1, 16.5] <0.001Plaque burden at MLA
(%)82.1 [46.8, 92.9] 60.3 [38.3, 89.6] <0.001Lesion length [mm] 31.1 [2.5, 92.5] 12.2 [1.5, 76.5] <0.001Mean vessel area
[mm3/mm]14.3 [7.1, 25.5] 12.9 [4.4, 30.5] 0.03Mean lumen area
[mm3/mm]6.1 [3.3, 12.0] 6.2 [2.4, 18.5] 0.24Mean plaque area
[mm3/mm]8.3 [3.5, 15.5] 6.4 [2.0, 17.0] <0.001Mean NC area [mm3/
mm]2.1 [0.4, 7.7] 1.5 [0.1, 7.6] <0.001Mean DC area [mm3/
mm]0.2 [0.02, 0.8] 0.1 [0.01, 0.7] <0.001Mean ﬁbrofatty area
[mm3/mm]0.6 [0.1, 2.0] 0.5 [0.9, 2.0] <0.001Mean Fibrotic area
[mm3/mm]4.8 [2.3, 8.6] 4.3 [1.5, 10.5] 0.001TCFA in entire lesion 39 (39.0%) 54 (19.0%) <0.001ThCFA in entire lesion 54 (54.0%) 171 (60.0%) 0.34PIT in entire lesion 7 (7.0%) 46 (16.1%) 0.05Fibrotic plaque in
entire lesion0 (0.0%) 14 (4.9%) 0.02CONCLUSIONS Three-vessel radiofrequency iMAP-IVUS study
demonstrated a greater prevalence of TCFAs in culprit vs non-culprit
lesions in pts presenting with STEMI or non-STEMI and undergoing
percutaneous intervention.
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BACKGROUND A thin ﬁbrous cap (FC) is associated with plaque
rupture and adverse events. Accurate measurements of FC thickness
by optical coherence tomography (OCT) is possible but only with
manual, point-by-point analyses which is dependent on human visual
assessment of the ﬁbrous cap border, subject to inter-observer vari-
ability and ignores the 3 dimensional morphology of the FC. We
developed and validated an automated computational methodology
for volumetric analysis of the FC and for determining true mean FC
thickness over the entire plaque.
METHODS Using a graph search algorithm, we developed a compu-
tational methodology for automatically outlining the FC border and
hence area, overlying an OCT cross-sectional lipid plaque. From a
single center OCT database we manually segmented the FC cross-
sectional (CS) area and surface length at 1mm intervals for the length
of 10 lipid plaques comprising 71 slices. FC volume was calculated as
the sum of these FC CS areas multiplied by the longitudinal interval
between measurements (1mm). The FC surface area was calculated as
the sum of FC surface lengths for each CS multiplied by the interval
between CS. The mean FC thickness over the entire plaque was
deﬁned as the FC volume/ FC surface area. The agreement between
manual and automatic segmentation for FC CS area, volume and mean
thickness was assessed by Bland-Altman plots and Pearson
correlation.
RESULTS With manual tracing, the mean FC CS area, FC volume, and
FC mean thickness were 0.770.39mm2, 5.484.83mm3, and
0.270.09mm, respectively. With automatic tracing, they were
0.650.29mm2, 4.624.03mm3, and 0.230.06mm. By Bland-Altman
analysis, the mean difference between manual and automatic tracing
for FC CS area, FC volume, and FC mean thickness is 0.119mm2(CI
0.078 to 0.16), 0.859mm3(CI 0.182 to 1.536), and 0.043mm (CI 0.017 to
0.068). The Pearson correlation coefﬁcient for manual and automatic
segmentation for FC CS area, FC volume, and FC mean thickness is
0.90, 0.99, and 0.97.
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area correlated well with human measurements, and can be used in
the future for volumetric assessments of the ﬁbrous cap with a high
degree of accuracy.
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BACKGROUND Culprit lesions in myocardial infarction frequently harbor
a lipid burden exceeding a maximum lipid-core burden index in 4-mm
(maxLCBI4mm) of 400, as deﬁned by intracoronary near-infrared spec-
troscopy (NIRS). Whether non-culprit atheroma with a plaque
burden 70% (PB70), the intravascular ultrasound (IVUS) characteristic
most strongly associated with future lesion-speciﬁc events, concurrently
harbor a maxLCBI4mm 400 remains unknown. Using hybrid NIRS-IVUS
imaging, the present analysis was undertaken to: 1) evaluate the correla-
tion between PB measured by IVUS and lipid burden measured by NIRS in
vivo; and 2) determine the prevalence of non-culprit PB70 lesions that
have a maxLCBI4mm 400 among non-culprit coronary atheroma.
METHODS Among consecutive patients undergoing NIRS-IVUS imag-
ing as part of a single center registry, non-culprit portions of the target
arteries were divided into contiguous 10-mm non-culprit segments.
PB in all segments was assessed by quantitative IVUS. Only lesions
having a PB 40% were included in the present analysis. NIRS-
derived lipid burden in all lesions was measured as maxLCBI4mm.
Summary statistics were used to describe the relationship between PB
and maxLCBI4mm within non-culprit lesions.
RESULTS In 121 patients, 292 non-culprit lesions (mean PB 56  10%)
were identiﬁed. A signiﬁcant but modest positive correlation was
found between PB and maxLCBI4mm (R¼0.32, 95% CI 0.22-0.42,
p<0.001, Figure). Although PB70 lesions had a greater maxLCBI4mm
than non-PB70 lesions (186 [51, 267] vs. 50 [0, 181], p ¼ 0.02), only
17.1% of PB70 lesions contained a maxLCBI4mm 400. PB70 lesions
having a maxLCBI4mm 400 were rare overall, accounting for only
2.1% of all non-culprit plaques.CONCLUSIONS We found a signiﬁcant yet modest positive correlation
between PB and lipid burden within non-culprit plaques. PB70 lesions
harboring a maxLCBI4mm 400 are proportionately rare and
accounted for only 2% of all non-culprit plaques. Whether these rare
lesions having the IVUS feature most predictive of site-speciﬁc future
events, coupled with a NIRS lipid burden characteristic of culprit le-
sions in myocardial infarction, will ultimately associate with future
acute coronary events remains unknown.
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BACKGROUND Color intensity and neointimal coverage after drug-
eluting stent (DES) evaluated by coronary angioscopy (CAS)maypredict
late stent failure and stent thrombosis. However, the histopathological
comparison data is limited. We evaluated the histological characteris-
tics of DES characterized by CAS in coronary autopsy specimens.
METHODS A total of 14 DESs were examined to compare CAS and
histological images. CAS examination was performed based on tissue
structure and color intensity classiﬁed either white or yellow. Stent
coverage was graded as 0, stent struts exposed; grade 1, struts bulging
into the lumen, but still transparently visible although covered; grade
2, struts embedded in the neointima, but translucent; grade 3, struts
fully embedded and invisible. Each examination was performed at
each 3-mm interval of the entire DES.
RESULTS Sixty-one segments were matched to CAS and histological
analysis. Of these, 37 were categorized as white and 24 were yellow on
CAS. Histological analysis revealed white segments was entirely
comprised of smooth muscle cells with an extracellular matrix containing
collagens, indicating high neointimal maturity. On the other hand, seg-
ments classiﬁed as yellow contained ﬁbroatheroma (n¼3), foam cells
accumulation (n¼12) or superﬁcial calcium deposition (n¼9) (Figure).
Intimal coverage grade was well correlated with histological neointimal
thickness (grade 0 [n ¼ 21] 109 mm, grade 1 [n ¼20] 11570 mm, grade 2
[n ¼12] 487 243 mm, and grade 3 [n ¼9] 969 404 mm; p<0.05).
CONCLUSIONS In-stent yellow intima includes various types of
atherosclerotic components, such as ﬁbroatheroma formation, foam
cell accumulation and superﬁcial calcium deposition. CAS has the
capability to evaluate vascular response of DES accurately.
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